Assessing Cervical Dystonia
Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Jul 13, 2018
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female participants aged 18 years or older (no upper age limit) and willing and able to provide informed consent.
- • Participant is able and willing to comply with the follow-up schedule and protocol.
- • Participants diagnosed with cervical dystonia.
- • Participant has previously received botulinum toxin therapy for cervical dystonia without adverse side effects OR is naïve to botulinum toxin therapy but is suitable to participate in the investigator's opinion
- Exclusion Criteria:
- • -Participated in another clinical investigation within 30 days.
- • Allergy to device components or botulinum toxin.
- • Medical co-morbidities that preclude botulinum toxin therapy.
- • Patient is incapable of understanding or responding to the study
About The Leeds Teaching Hospitals Nhs Trust
The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, West Yorkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials